Author: eczemarelief
Primary failures vs secondary failures for therapy, differences in pathophysiology across different ethnic groups, and adult-onset disease are 3 key topics that are either being investigated or warrant further study among patients with atopic dermatitis (AD), said Jason Ezra Hawkes, MD, MS, FAAD, board-certified dermatologist and associate professor of dermatology at the University of California […]
Reistone Biopharma Co. Ltd. said both doses of the JAK1 inhibitor ivarmacitinib, tested against moderate to severe atopic dermatitis (AD) in a multinational phase III trial, met the study’s co-primary endpoints, delivering significant improvements on a common measure of disease severity vs. placebo. It’s the first National Class A new drug for AD that is […]
St. Mary’s Hospital, which once conducted business at 828 W. Second St., provided treatments for a variety of medical issues, from sinus infections to eczema, and most ailments in between. The establishment was founded in 1923 by Emil Roos, an immigrant from Switzerland who arrived in this country in 1914. When Roos opened his clinic, […]
Results from the test reveal that high levels of the immune biomarker Thymus and Activation-Regulated Chemokine (TARC) in babies increases their chances of developing atopic dermatitis. There is a non-invasive test that may help predict eczema development in babies, according to a study published in BMJ Open. This test was conducted by researchers at the […]